ClearPoint Neuro tillkännager sin första EU MDR-certifiering och godkännande att skicka produkter till Europa
January 22, 2024 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Kalif., Jan. 22, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (”Företaget”), ett globalt företag inom medicinteknik och cell- och genterapi som erbjuder exakt...
ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
January 16, 2024 08:00 ET
|
ClearPoint Neuro, Inc.
ClearPoint Neuro received 510(k) clearance for SmartFrame OR, first product in company history designed for the operating room instead of the MRI suite.
ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue
January 08, 2024 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Reports Third Quarter 2023 Results
November 09, 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023
October 26, 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Reports Second Quarter 2023 Results
August 08, 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Announce Second Quarter 2023 Results August 8, 2023
July 25, 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro y UCB firman un acuerdo de licencia para la administración de fármacos de terapia génica
May 25, 2023 08:51 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, California, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), una empresa global de plataformas habilitadoras de terapias que ofrecen navegación y administración...
ClearPoint Neuro e UCB stipulano un contratto di licenza per la somministrazione di farmaci per la terapia genetica
May 25, 2023 08:51 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, California, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), società globale di piattaforme terapeutiche che fornisce navigazione e somministrazione al cervello,...
ClearPoint Neuro et UCB concluent un accord de licence pour l'administration de médicaments de thérapie génique
May 25, 2023 08:51 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Californie, 25 mai 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ : CLPT), une société mondiale de plateformes thérapeutiques permettant la navigation et l'administration vers...